{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:51:35Z","timestamp":1770987095958,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.euo.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T20:43:34Z","timestamp":1734468214000},"page":"739-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection"],"prefix":"10.1016","volume":"8","author":[{"given":"Rosemarijn H.","family":"Ettema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Jaap J.","family":"Mellema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennie","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik H.K.","family":"Oudshoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wietske I.","family":"Luining","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk G.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten L.","family":"Donswijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"van der Gaag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marnix G.E.H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela E.","family":"Oprea-Lager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 N.","family":"Vis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.11.003_b0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ije\/dyac238","article-title":"Lifestyle, genetic risk and incidence of cancer: a prospective cohort study of 13 cancer types","volume":"52","author":"Byrne","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.euo.2024.11.003_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","article-title":"Disparities and trends in genitourinary cancer incidence and mortality in the USA","volume":"84","author":"Schafer","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2024.11.003_b0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.eururo.2022.11.002","article-title":"Management of patients with advanced prostate cancer. Part I: intermediate-\/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment: report of the Advanced Prostate Cancer Consensus Conference 2022","volume":"83","author":"Gillessen","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II\u20132024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2024.11.003_b0040","doi-asserted-by":"crossref","first-page":"205.e17","DOI":"10.1016\/j.urolonc.2022.12.006","article-title":"A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and (18)F-PSMA-PET\/CT","volume":"41","author":"Bodar","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2024.11.003_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pros.24627","article-title":"The diagnostic accuracy of (68) Ga-PSMA-PET\/CT in primary staging of patients with high-risk nonmetastatic prostate cancer treated with radical prostatectomy: a single-center cohort analysis","volume":"84","author":"Rajwa","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2024.11.003_b0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2967\/jnumed.117.202945","article-title":"Impact of (68)Ga-PSMA-11 PET\/CT on the management of prostate cancer patients with biochemical recurrence","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2024.11.003_b0060","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00259-021-05222-5","article-title":"Management impact of (18)F-DCFPyL PET\/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study","volume":"48","author":"Meijer","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2024.11.003_b0065","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0070","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/0284186X.2022.2129442","article-title":"Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with (68)Ga-PSMA PET\/CT","volume":"61","author":"Klingenberg","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euo.2024.11.003_b0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00259-020-05058-5","article-title":"Improved oncological outcome after radical prostatectomy in patients staged with (68)Ga-PSMA-11 PET: a single-center retrospective cohort comparison","volume":"48","author":"Ferraro","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2024.11.003_b0080","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190193","article-title":"Diagnostic accuracy of (F)18 flucholine PET\/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis","volume":"92","author":"Kim","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.euo.2024.11.003_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203400","article-title":"Diagnostic performance of choline PET\/CT for the detection of bone metastasis in prostate cancer: a systematic review and meta-analysis","volume":"13","author":"Guo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2024.11.003_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MNM.0000000000000040","article-title":"Meta-analysis of (11)C-choline and (18)F-choline PET\/CT for management of patients with prostate cancer","volume":"35","author":"von Eyben","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.euo.2024.11.003_b0095","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199304293281706","article-title":"Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy","volume":"328","author":"Black","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2024.11.003_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","article-title":"Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review","volume":"68","author":"Valerio","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.11.003_b0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2011.08.045","article-title":"Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years","volume":"79","author":"Suardi","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euo.2024.11.003_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.695251","article-title":"Clinicopathological analysis of the ISUP grade group and other parameters in prostate cancer: elucidation of mutual impact of the various parameters","volume":"11","author":"Okubo","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2024.11.003_b0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2024.11.003_b0120","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124002505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124002505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:55:24Z","timestamp":1748451324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931124002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2588931124002505"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.11.003","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}